期刊文献+

怡开治疗2型糖尿病早期肾病的疗效观察 被引量:2

Observation of curative effect on early diabetic nephropathy of type 2 Diabetes treated by Yikai
下载PDF
导出
摘要 目的 :观察怡开 (胰激肽原酶肠溶片 )对 2型糖尿病 (T2DM)早期肾病的疗效。方法 :5 8例T2DM早期肾病患者 ,随机分成对照组和治疗组 ,在常规降糖药物治疗同时 ,治疗组口服怡开 ,3个月后比较治疗前后尿微量白蛋白 (UAER)的变化。结果 :怡开组治疗后可显著减少尿微量白蛋白的排出量 (P <0 .0 1 ) ,对照组治疗前后UAER无明显差异 (P >0 .0 5 )。结论 :怡开可降低糖尿病尿微量白蛋白的排泄 。 Objective: To study the curative effect of YiKai(pancreatic kininogenase tablets) in the treatment of early diabetic nephropathy of type 2 diabetes. Method:50 patients with early diabetic nephropathy of type 2 diabetes were divided randomly into two groups: control group and treatment group.While treated with general hypoglycemic agent,the treatment group took Yikai orally for 3 months.After 3 months, compare the uninary albumin excretory rate(UAER)before and after therapy. Result: There was significant decrease of UAER in treatment group after therapy(P<0.01) and no significant difference in control group(P>0.05). Conclusion: Yikai can decrease UAER in patients and has a favorable curative effect on early diabetic nephropathy of type 2 diabetes.
作者 张红梅
出处 《河北医学》 CAS 2003年第10期911-913,共3页 Hebei Medicine
关键词 怡开(胰激肽原酶) 2型糖尿病 尿微量白蛋白 Yikai Type 2 diabetes mellitus Mieoal buminaria
  • 引文网络
  • 相关文献

参考文献2

  • 1陈坚梅.胰激肽释放酶治疗糖尿病肾病临床观察.实用糖尿病杂志,1995,3:45-45.
  • 2吴石白 朱西娥.胰激肽释放酶片治疗糖尿病肾病白蛋白尿20例临床观察.中国糖尿病杂志,1999,7:237-237.

共引文献16

同被引文献48

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部